Syk Inhibitor Treats Rheumatoid Arthritis in Trial

Syk Inhibitor R788 proven effective in treating rheumatoid arthritis.

Investigational Syk inhibitor R788 was proven effective in treating rheumatoid arthritis in a study by researchers from Brigham and Women’s Hospital and Harvard Medical School that was published in the New England Journal of Medicine.

The following video describes the study and discusses rheumatoid arthritis. Click here to access this third-party resource.